Written answers

Tuesday, 15 February 2022

Department of Health

Medical Aids and Appliances

Photo of Cormac DevlinCormac Devlin (Dún Laoghaire, Fianna Fail)
Link to this: Individually | In context | Oireachtas source

64. To ask the Minister for Health if a decision has been made in relation to the long-awaited roll-out of the FreeStyle Libre flash glucose monitoring system to persons with diabetes over 21 years of age based on clinical need. [7927/22]

Photo of Stephen DonnellyStephen Donnelly (Wicklow, Fianna Fail)
Link to this: Individually | In context | Oireachtas source

I am aware that the FreeStyle Libre flash glucose monitoring system makes a real difference to patients living with type 1 diabetes by enabling needle-free monitoring of blood sugars.

Currently, access to the Freestyle Libre glucose monitoring system is available to children and young adults, aged 4 - 21 years.

However, I want to ensure that the device is made available to all patients. Age should not be a barrier.

There is an exceptional application process in place for type 1 diabetic patients outside of the 4–21 age cohort. I appreciate that this exceptional process is not ideal and that is why I want it readily available for all patients that require it.

The HSE, in 2021, commissioned the National Centre for Pharmacoeconomics (NCPE) to conduct a full Health Technology Assessment (HTA) of the device.

However, the company responsible for the device has expressed a preference to submit evidence to support its effectiveness to the HSE Health Technology Advisory Group for their consideration.

I do not want any further unnecessary delays for patients. Therefore, I have written to the HSE requesting that it be assessed by the Health Technology Advisory Group without any further delay.

Comments

No comments

Log in or join to post a public comment.